logo

Astria Therapeutics Inc’s Banking’s 100-Day Moving Average at 9.00: Will the Stock Break Through?

CSCO Stock

The market performance of Astria Therapeutics Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $16.20 on 03/19/24, while the lowest value for the same duration was $4.26 on 11/17/23.

52-week price history of ATXS Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Astria Therapeutics Inc’s current trading price is 3.02% away from its 52-week high, while its distance from the 52-week low is 291.78%. The stock’s price range during this period has spanned from $4.26 to $16.20. In the Healthcare sector, the Astria Therapeutics Inc’s shares surpassed a trading volume of approximately 1.83 million for the day, which was noticeably higher compared to the average daily volume of 9.0.92 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Astria Therapeutics Inc (ATXS) has experienced a quarterly rise of 167.04% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 916.28M and boasts a workforce of 59 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 9.00, with a change in price of +12.05. Similarly, Astria Therapeutics Inc recorded 704,704 in trading volume during the last 100 days, posting a change of +259.70%.

Examining ATXS’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ATXS stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

ATXS Stock Stochastic Average

Today, Astria Therapeutics Inc’s raw stochastic average for the past 50 days stands at 98.89%, indicating a rise from the raw stochastic average of the last 20 days, which was 97.58%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 89.11% and 83.52% respectively.

ATXS Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price gain of 117.32% this year. Over the last six months, there has been a weaker performance of 122.24%. The price of ATXS fallen by 19.47% during the last 30 days period. For the last 5-days stocks have improved 15.26%.